Carbon monoxide poisoning is a toxic condition caused by inhalation of carbon monoxide (CO), a colorless, odorless gas produced by incomplete combustion of carbon-containing fuels. Common sources include faulty furnaces and heaters, fire smoke, motor vehicle exhaust, portable generators, indoor charcoal burning, and the metabolic conversion of inhaled methylene chloride (paint stripper). CO produces tissue hypoxia through several converging mechanisms: it binds hemoglobin with roughly 200 times the affinity of oxygen to form carboxyhemoglobin, reducing the oxygen-carrying capacity of blood and shifting the oxyhemoglobin dissociation curve leftward so that less oxygen is released to tissues; it binds and inhibits mitochondrial cytochrome c oxidase, causing histotoxic (cellular) hypoxia; and it triggers an oxidative and inflammatory cascade of platelet-neutrophil activation, reactive oxygen species, and lipid peroxidation that drives delayed neurological injury. The brain and heart, as the most oxygen-dependent organs, are most vulnerable. Clinical features range from headache, dizziness, nausea, and confusion to syncope, seizures, myocardial injury, coma, and death; a subset of survivors develop delayed neuropsychiatric sequelae. Treatment centers on high-flow normobaric oxygen and, for severe poisoning, hyperbaric oxygen therapy.
Ask a research question about Carbon Monoxide Poisoning. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
name: Carbon Monoxide Poisoning
creation_date: "2026-07-09T00:00:00Z"
category: Environmental
categories:
- Toxic Exposure Disorder
- Environmental Health Disorder
- Gas Poisoning
synonyms:
- CO poisoning
- carbon monoxide toxicity
- carbon monoxide intoxication
description: >-
Carbon monoxide poisoning is a toxic condition caused by inhalation of carbon
monoxide (CO), a colorless, odorless gas produced by incomplete combustion of
carbon-containing fuels. Common sources include faulty furnaces and heaters,
fire smoke, motor vehicle exhaust, portable generators, indoor charcoal
burning, and the metabolic conversion of inhaled methylene chloride (paint
stripper). CO produces tissue hypoxia through several converging mechanisms:
it binds hemoglobin with roughly 200 times the affinity of oxygen to form
carboxyhemoglobin, reducing the oxygen-carrying capacity of blood and shifting
the oxyhemoglobin dissociation curve leftward so that less oxygen is released
to tissues; it binds and inhibits mitochondrial cytochrome c oxidase, causing
histotoxic (cellular) hypoxia; and it triggers an oxidative and inflammatory
cascade of platelet-neutrophil activation, reactive oxygen species, and lipid
peroxidation that drives delayed neurological injury. The brain and heart, as
the most oxygen-dependent organs, are most vulnerable. Clinical features range
from headache, dizziness, nausea, and confusion to syncope, seizures,
myocardial injury, coma, and death; a subset of survivors develop delayed
neuropsychiatric sequelae. Treatment centers on high-flow normobaric oxygen
and, for severe poisoning, hyperbaric oxygen therapy.
disease_term:
preferred_term: carbon monoxide poisoning
term:
id: MONDO:0800373
label: carbon monoxide poisoning
mappings:
mondo_mappings:
- term:
id: MONDO:0800373
label: carbon monoxide poisoning
mapping_predicate: skos:exactMatch
mapping_source: MONDO
mapping_justification: Primary MONDO disease identifier for this carbon monoxide poisoning entry.
definitions:
- name: Clinical case definition for carbon monoxide poisoning
definition_type: CASE_DEFINITION
description: >-
Carbon monoxide poisoning is a toxic-inhalation syndrome in which carbon
monoxide binds hemoglobin and other heme proteins, producing tissue hypoxia
and oxidative stress, confirmed by an elevated blood carboxyhemoglobin level
in a compatible clinical and exposure context.
scope: Disease-level clinical framing across acute poisoning and delayed sequelae
evidence:
- reference: PMID:34053712
reference_title: "Carbon Monoxide Poisoning."
supports: SUPPORT
evidence_source: OTHER
snippet: "Carbon monoxide binds to hemoglobin and other heme molecules, causing tissue hypoxia and oxidative stress."
explanation: Supports the core disease framing as heme-protein binding producing tissue hypoxia and oxidative stress.
- reference: PMID:34053712
reference_title: "Carbon Monoxide Poisoning."
supports: SUPPORT
evidence_source: OTHER
snippet: "When there is concern for possible carbon monoxide poisoning, the diagnosis can be made via blood co-oximetry."
explanation: Supports blood co-oximetry (carboxyhemoglobin measurement) as the confirmatory diagnostic anchor.
parents:
- gas poisoning
prevalence:
- population: United States
measure_type: ANNUAL_INCIDENCE
prevalence_class: COMMON
rate_per_100000: 15.1
notes: >-
Approximately 50,000 people affected per year in the United States
(normalized to the US population as roughly 15 per 100,000 per year).
Modeled as an annual incidence of acute poisoning, not a chronic point
prevalence.
evidence:
- reference: PMID:27753502
reference_title: "Carbon Monoxide Poisoning: Pathogenesis, Management, and Future Directions of Therapy."
supports: SUPPORT
evidence_source: OTHER
snippet: "Carbon monoxide (CO) poisoning affects 50,000 people a year in the United States."
explanation: Provides the US annual burden used to derive the normalized incidence rate.
has_subtypes:
- name: Acute CO Poisoning
description: >-
Acute carbon monoxide poisoning follows a high-level exposure and presents
with headache, dizziness, altered mental status, syncope, seizures,
myocardial injury, coma, or death depending on the carboxyhemoglobin level
and duration of exposure.
evidence:
- reference: PMID:35461624
reference_title: "Carbon Monoxide Toxicity."
supports: SUPPORT
evidence_source: OTHER
snippet: "Clinical effects can be diverse and include headache, dizziness, nausea, vomiting, syncope, seizures, coma, dysrhythmias, and cardiac ischemia, and severe toxicity generally affects the nervous and cardiovascular systems."
explanation: Supports the acute multisystem presentation of carbon monoxide poisoning.
- name: Delayed Neuropsychiatric Sequelae
display_name: Delayed Neurological Sequelae (DNS)
description: >-
A subset of survivors of acute CO poisoning develop delayed neuropsychiatric
sequelae days to weeks after apparent recovery, including cognitive
impairment, memory loss, parkinsonism, and behavioral changes, associated
with demyelination and basal-ganglia (globus pallidus) injury.
evidence:
- reference: PMID:26563790
reference_title: "Carbon monoxide intoxication."
supports: SUPPORT
evidence_source: OTHER
snippet: "Following resolution of acute symptoms there may be a lucid interval of 2-40 days before the development of delayed neurologic sequelae (DNS), with diffuse demyelination in the brain accompanied by lethargy, behavior changes, forgetfulness, memory loss, and parkinsonian features."
explanation: Directly supports the delayed neuropsychiatric sequelae subtype and its demyelinating, biphasic character.
pathophysiology:
- name: Carboxyhemoglobin formation
description: >-
Inhaled carbon monoxide binds hemoglobin at the same heme iron sites used by
oxygen, with an affinity roughly 200 times that of oxygen, forming
carboxyhemoglobin (COHb). This reduces the oxygen-carrying capacity of blood.
cell_types:
- preferred_term: erythrocyte
term:
id: CL:0000232
label: erythrocyte
biological_processes:
- preferred_term: oxygen transport
modifier: DECREASED
term:
id: GO:0015671
label: oxygen transport
downstream:
- target: Impaired tissue oxygen delivery
description: Reduced oxygen-carrying capacity and leftward-shifted dissociation curve limit oxygen delivery and offloading to tissues.
evidence:
- reference: PMID:26563790
reference_title: "Carbon monoxide intoxication."
supports: SUPPORT
evidence_source: OTHER
snippet: "Once CO is inhaled it binds with hemoglobin to form carboxyhemoglobin (COHb) with an affinity 200 times greater than oxygen that leads to decreased oxygen-carrying capacity and decreased release of oxygen to tissues leading to tissue hypoxia."
explanation: Links carboxyhemoglobin formation to reduced oxygen delivery and tissue hypoxia.
evidence:
- reference: PMID:26563790
reference_title: "Carbon monoxide intoxication."
supports: SUPPORT
evidence_source: OTHER
snippet: "Once CO is inhaled it binds with hemoglobin to form carboxyhemoglobin (COHb) with an affinity 200 times greater than oxygen that leads to decreased oxygen-carrying capacity and decreased release of oxygen to tissues leading to tissue hypoxia."
explanation: Directly supports carboxyhemoglobin formation with ~200x oxygen affinity and reduced oxygen-carrying capacity.
- name: Leftward shift of the oxyhemoglobin dissociation curve
description: >-
Binding of CO to one or more heme sites increases the oxygen affinity of the
remaining sites on the hemoglobin tetramer, shifting the oxyhemoglobin
dissociation curve to the left so that bound oxygen is released less readily
at the tissues, worsening tissue hypoxia beyond what the reduced
oxygen-carrying capacity alone would cause.
cell_types:
- preferred_term: erythrocyte
term:
id: CL:0000232
label: erythrocyte
downstream:
- target: Impaired tissue oxygen delivery
description: The impaired oxygen release compounds the hypoxic insult.
evidence:
- reference: PMID:26563790
reference_title: "Carbon monoxide intoxication."
supports: SUPPORT
evidence_source: OTHER
snippet: "decreased release of oxygen to tissues leading to tissue hypoxia"
explanation: Supports impaired oxygen offloading (the functional consequence of the leftward shift) as a driver of tissue hypoxia.
- name: Impaired tissue oxygen delivery
description: >-
The combination of reduced carboxyhemoglobin-limited oxygen carriage and
impaired oxygen offloading produces systemic tissue hypoxia, most severely
affecting the oxygen-dependent brain and heart.
biological_processes:
- preferred_term: cellular response to hypoxia
modifier: INCREASED
term:
id: GO:0071456
label: cellular response to hypoxia
downstream:
- target: Cerebral hypoxic-ischemic injury
description: Hypoxia in the brain produces neuronal injury and encephalopathy.
- target: Myocardial ischemic injury
description: Hypoxia in the heart produces myocardial ischemia and injury.
evidence:
- reference: PMID:34053712
reference_title: "Carbon Monoxide Poisoning."
supports: SUPPORT
evidence_source: OTHER
snippet: "Carbon monoxide binds to hemoglobin and other heme molecules, causing tissue hypoxia and oxidative stress."
explanation: Supports systemic tissue hypoxia as the central consequence of carbon monoxide binding.
- name: Cytochrome c oxidase inhibition
description: >-
Carbon monoxide binds the ferrous iron of mitochondrial cytochrome c oxidase
(Complex IV of the electron transport chain), directly inhibiting oxidative
phosphorylation. This produces histotoxic (cellular) hypoxia independent of
oxygen delivery, impairing ATP generation even where oxygen is present, and
helps explain the persistence of symptoms after carboxyhemoglobin normalizes.
biological_processes:
- preferred_term: oxidative phosphorylation
modifier: DECREASED
term:
id: GO:0006119
label: oxidative phosphorylation
- preferred_term: mitochondrial electron transport, cytochrome c to oxygen
modifier: DECREASED
term:
id: GO:0006123
label: mitochondrial electron transport, cytochrome c to oxygen
downstream:
- target: Cellular energy failure
description: Inhibition of oxidative phosphorylation depletes cellular ATP.
- target: Oxidative stress and free radical generation
description: Mitochondrial dysfunction generates reactive oxygen species and free radicals.
evidence:
- reference: PMID:9584335
reference_title: "Mitochondrial cytochrome c oxidase inhibition during acute carbon monoxide poisoning."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "cytochrome c oxidase (complex IV) activity showed a 76% inhibition compared to controls during acute poisoning (P < 0.01) and 48% at day 3 (P < 0.05)."
explanation: Direct human evidence of marked cytochrome c oxidase inhibition during acute CO poisoning.
- reference: PMID:9584335
reference_title: "Mitochondrial cytochrome c oxidase inhibition during acute carbon monoxide poisoning."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Our results suggest that mitochondrial cytochrome c oxidase is also a target site in human acute CO poisoning, and its extended and generalized inhibition could explain the persistence of different symptoms after the normalization of HbCO levels."
explanation: Supports cytochrome c oxidase as a COHb-independent target explaining persistent symptoms.
- name: Cellular energy failure
description: >-
Inhibition of oxidative phosphorylation, together with tissue hypoxia,
depletes cellular ATP and forces a shift to anaerobic metabolism, producing
lactic acidosis and cellular energy failure across multiple organs.
biological_processes:
- preferred_term: aerobic respiration
modifier: DECREASED
term:
id: GO:0009060
label: aerobic respiration
downstream:
- target: Xanthine oxidase-mediated reactive oxygen species generation
description: Energy deprivation and purine catabolism drive conversion of xanthine dehydrogenase to reactive-oxygen-species-generating xanthine oxidase.
evidence:
- reference: PMID:27753502
reference_title: "Carbon Monoxide Poisoning: Pathogenesis, Management, and Future Directions of Therapy."
supports: SUPPORT
evidence_source: OTHER
snippet: "likely result from the pleiotropic effects of CO on cellular mitochondrial respiration, cellular energy utilization, inflammation, and free radical generation, especially in the brain and heart."
explanation: Supports impaired cellular energy utilization as a core downstream effect of CO.
- name: Oxidative stress and free radical generation
description: >-
Mitochondrial dysfunction and the displacement of nitric oxide from
hemoproteins generate reactive oxygen species, free radicals, and
nitric-oxide-derived species, producing oxidative injury across multiple
organs.
biological_processes:
- preferred_term: response to oxidative stress
modifier: INCREASED
term:
id: GO:0006979
label: response to oxidative stress
downstream:
- target: Platelet-neutrophil activation
description: Nitric-oxide displacement and oxidative changes promote intravascular platelet-neutrophil activation.
- target: Brain lipid peroxidation
description: Reactive oxygen species peroxidize brain membrane and myelin lipids.
evidence:
- reference: PMID:24773392
reference_title: "The role of reactive oxygen species and oxidative stress in carbon monoxide toxicity: an in-depth analysis."
supports: SUPPORT
evidence_source: OTHER
snippet: "One of the current hypotheses with regard to the molecular mechanism of CO poisoning is the oxidative injury induced by reactive oxygen species, free radicals, and neuronal nitric oxide."
explanation: Supports oxidative injury by reactive oxygen species, free radicals, and nitric oxide as a core molecular mechanism.
- name: Platelet-neutrophil activation
description: >-
Acute CO poisoning triggers intravascular platelet-neutrophil aggregation and
neutrophil activation with myeloperoxidase release, initiating a
reperfusion-injury-like oxidative cascade in the cerebral microvasculature.
cell_types:
- preferred_term: neutrophil
term:
id: CL:0000775
label: neutrophil
biological_processes:
- preferred_term: platelet aggregation
modifier: INCREASED
term:
id: GO:0070527
label: platelet aggregation
- preferred_term: inflammatory response
modifier: INCREASED
term:
id: GO:0006954
label: inflammatory response
downstream:
- target: Xanthine oxidase-mediated reactive oxygen species generation
description: Neutrophil adherence to the cerebral microvasculature drives conversion of xanthine dehydrogenase to xanthine oxidase.
evidence:
- reference: PMID:8248931
reference_title: "Leukocytes in carbon monoxide-mediated brain oxidative injury."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Neither of these groups of animals exhibited the biochemical changes observed in the brains of sham-treated rats: conversion of xanthine dehydrogenase (XD) to sulfhydryl-irreversible xanthine oxidase (XO), and lipid peroxidation, at 90 min following CO poisoning."
explanation: Blocking leukocyte adherence prevents the xanthine oxidase conversion and lipid peroxidation, linking neutrophil activation to the oxidative cascade.
evidence:
- reference: PMID:16931637
reference_title: "Intravascular neutrophil activation due to carbon monoxide poisoning."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Acute CO poisoning causes intravascular neutrophil activation due to interactions with platelets."
explanation: Directly supports platelet-driven intravascular neutrophil activation in CO poisoning.
- reference: PMID:16931637
reference_title: "Intravascular neutrophil activation due to carbon monoxide poisoning."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Platelet-neutrophil aggregates were detected and plasma myeloperoxidase (MPO) concentration was significantly elevated in those with confirmed CO poisoning."
explanation: Human patient data confirm platelet-neutrophil aggregates and myeloperoxidase release in confirmed CO poisoning.
- name: Xanthine oxidase-mediated reactive oxygen species generation
description: >-
Energy deprivation and neutrophil-driven signaling convert xanthine
dehydrogenase to xanthine oxidase, which generates reactive oxygen species
and drives a postischemic reperfusion-like oxidative injury in the brain.
biological_processes:
- preferred_term: reactive oxygen species metabolic process
modifier: INCREASED
term:
id: GO:0072593
label: reactive oxygen species metabolic process
downstream:
- target: Brain lipid peroxidation
description: Xanthine oxidase-derived reactive oxygen species peroxidize brain lipids.
evidence:
- reference: PMID:1447108
reference_title: "Dehydrogenase conversion to oxidase and lipid peroxidation in brain after carbon monoxide poisoning."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "These results are consistent with the view that CO-mediated brain injury is a type of postischemic reperfusion phenomenon and indicate that xanthine oxidase-derived reactive oxygen species are responsible for lipid peroxidation."
explanation: Rat data link xanthine oxidase-derived reactive oxygen species to brain lipid peroxidation.
evidence:
- reference: PMID:1447108
reference_title: "Dehydrogenase conversion to oxidase and lipid peroxidation in brain after carbon monoxide poisoning."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "The conversion of xanthine dehydrogenase to xanthine oxidase and lipid peroxidation were measured in brain from carbon monoxide- (CO) poisoned rats."
explanation: Supports xanthine dehydrogenase-to-oxidase conversion generating the oxidative injury.
- reference: PMID:24773392
reference_title: "The role of reactive oxygen species and oxidative stress in carbon monoxide toxicity: an in-depth analysis."
supports: SUPPORT
evidence_source: OTHER
snippet: "The underlying mechanism of the central nervous system (CNS) injury after acute carbon monoxide (CO) poisoning is interlaced with multiple factors including apoptosis, abnormal inflammatory responses, hypoxia, and ischemia/reperfusion-like problems."
explanation: Supports the ischemia/reperfusion-like oxidative character of the injury.
- name: Brain lipid peroxidation
description: >-
Reactive oxygen species peroxidize brain membrane and myelin lipids.
Peroxidation products such as malondialdehyde form adducts with myelin basic
protein, generating the antigenic modification that initiates delayed injury.
biological_processes:
- preferred_term: lipid oxidation
modifier: INCREASED
term:
id: GO:0034440
label: lipid oxidation
downstream:
- target: Immune-mediated neuroinflammation
description: Adducts between peroxidation products and myelin basic protein become antigenic and initiate an immune response.
evidence:
- reference: PMID:2341364
reference_title: "Carbon monoxide-mediated brain lipid peroxidation in the rat."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "brain lipid peroxidation could be documented as a result of exposure to CO at a concentration sufficient to cause unconsciousness."
explanation: Rat data support brain lipid peroxidation as a downstream consequence of CO exposure.
- reference: PMID:15342916
reference_title: "Delayed neuropathology after carbon monoxide poisoning is immune-mediated."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "CO poisoning also causes adduct formation between myelin basic protein (MBP) and malonylaldehyde, a reactive product of lipid peroxidation, resulting in an immunological cascade."
explanation: Supports myelin basic protein adduct formation from lipid peroxidation initiating an immunological cascade.
- name: Immune-mediated neuroinflammation
description: >-
Chemically modified myelin basic protein becomes antigenic, provoking an
adaptive immune response with macrophage and CD4+ lymphocyte influx and
microglial activation that drives delayed central nervous system injury.
cell_types:
- preferred_term: microglial cell
term:
id: CL:0000129
label: microglial cell
biological_processes:
- preferred_term: adaptive immune response
modifier: INCREASED
term:
id: GO:0002250
label: adaptive immune response
downstream:
- target: Delayed demyelination
description: The adaptive immune response against modified myelin basic protein drives demyelination.
evidence:
- reference: PMID:15342916
reference_title: "Delayed neuropathology after carbon monoxide poisoning is immune-mediated."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "These results demonstrate that delayed CO-mediated neuropathology is linked to an adaptive immunological response to chemically modified MBP."
explanation: Rat data establish the adaptive immune response to modified myelin basic protein as the cause of delayed neuropathology.
evidence:
- reference: PMID:15342916
reference_title: "Delayed neuropathology after carbon monoxide poisoning is immune-mediated."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Immunohistochemical evidence of degraded MBP occurs in brain over days, along with influx of macrophages and CD-4 lymphocytes."
explanation: Supports progressive immune-mediated myelin degradation with macrophage and CD4 lymphocyte influx.
- name: Cerebral hypoxic-ischemic injury
description: >-
Acute hypoxia preferentially injures metabolically demanding regions of the
brain, including the basal ganglia (especially the globus pallidus) and deep
white matter, producing acute encephalopathy and a substrate for later
parkinsonism and cognitive dysfunction.
cell_types:
- preferred_term: neuron
term:
id: CL:0000540
label: neuron
biological_processes:
- preferred_term: positive regulation of neuron apoptotic process
modifier: INCREASED
term:
id: GO:0043525
label: positive regulation of neuron apoptotic process
downstream:
- target: Delayed neuronal injury
description: Acute ischemic injury and ongoing oxidative-inflammatory injury converge on delayed neuronal injury.
evidence:
- reference: PMID:26563790
reference_title: "Carbon monoxide intoxication."
supports: SUPPORT
evidence_source: OTHER
snippet: "White-matter damage in the centrum semiovale and periventricular area and abnormalities in the globus pallidus are most commonly seen on MRI following CO exposure."
explanation: Supports the characteristic globus pallidus and white-matter localization of CO brain injury.
- reference: PMID:16537269
reference_title: "Basal ganglia lesions following carbon monoxide poisoning."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Carbon monoxide (CO) is the most common cause of poisoning and may result in basal ganglia lesions."
explanation: Human cohort/literature review supports basal ganglia lesions as a consequence of CO poisoning.
- name: Delayed demyelination
description: >-
Days to weeks after acute poisoning, immune-mediated demyelination of
cerebral white matter produces the leukoencephalopathy characteristic of
delayed neurological sequelae.
cell_types:
- preferred_term: oligodendrocyte
term:
id: CL:0000128
label: oligodendrocyte
biological_processes:
- preferred_term: myelination
modifier: ABNORMAL
term:
id: GO:0042552
label: myelination
downstream:
- target: Delayed neuronal injury
description: White-matter demyelination contributes to delayed neuronal dysfunction and injury.
evidence:
- reference: PMID:27753502
reference_title: "Carbon Monoxide Poisoning: Pathogenesis, Management, and Future Directions of Therapy."
supports: SUPPORT
evidence_source: OTHER
snippet: "Imaging studies reveal cerebral white matter hyperintensities, with delayed posthypoxic leukoencephalopathy or diffuse brain atrophy."
explanation: Supports delayed white-matter (demyelinating) injury demonstrated on imaging.
- name: Delayed neuronal injury
description: >-
Immune-mediated and hypoxic-ischemic injury converge on neuronal loss,
particularly in basal ganglia and hippocampus, producing the delayed
neuropsychiatric sequelae of cognitive impairment, memory loss, and
parkinsonism.
cell_types:
- preferred_term: neuron
term:
id: CL:0000540
label: neuron
biological_processes:
- preferred_term: neuron apoptotic process
modifier: INCREASED
term:
id: GO:0051402
label: neuron apoptotic process
evidence:
- reference: PMID:15342916
reference_title: "Delayed neuropathology after carbon monoxide poisoning is immune-mediated."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "CO poisoning causes a decrement in learning that is not observed in immunologically tolerant rats."
explanation: Rat data link the immune-mediated injury to a functional learning deficit, the model correlate of delayed neuronal injury.
- name: Myocardial ischemic injury
description: >-
Reduced oxygen delivery, direct binding of CO to myoglobin, and mitochondrial
dysfunction impair cardiac oxygen supply and utilization, producing
myocardial stunning, ischemia, left ventricular dysfunction, and arrhythmia;
myocardial injury predicts increased short- and long-term mortality.
cell_types:
- preferred_term: cardiac muscle cell
term:
id: CL:0000746
label: cardiac muscle cell
biological_processes:
- preferred_term: cellular response to hypoxia
modifier: INCREASED
term:
id: GO:0071456
label: cellular response to hypoxia
evidence:
- reference: PMID:24518173
reference_title: "Cardiovascular Abnormalities in Carbon Monoxide Poisoning."
supports: SUPPORT
evidence_source: OTHER
snippet: "Cardiovascular complications of CO poisoning has been well reported and include myocardial stunning, left ventricular dysfunction, pulmonary edema, and arrhythmias."
explanation: Supports the myocardial injury phenotype (stunning, LV dysfunction, arrhythmia) of CO poisoning.
- reference: PMID:24518173
reference_title: "Cardiovascular Abnormalities in Carbon Monoxide Poisoning."
supports: SUPPORT
evidence_source: OTHER
snippet: "Myocardial toxicity from CO exposure is associated with increased short-term and long-term mortality."
explanation: Supports the prognostic significance of CO-related myocardial injury.
phenotypes:
- category: Nervous System
name: Headache
frequency: FREQUENT
description: >-
Headache is the most common presenting symptom of carbon monoxide poisoning,
reflecting cerebral hypoxia.
phenotype_term:
preferred_term: headache
term:
id: HP:0002315
label: Headache
evidence:
- reference: PMID:26563790
reference_title: "Carbon monoxide intoxication."
supports: SUPPORT
evidence_source: OTHER
snippet: "The initial symptoms with CO exposure when COHb is 15-30% are nonspecific, namely, headache, dizziness, nausea, fatigue, and impaired manual dexterity."
explanation: >-
Supports headache as an initial symptom of CO exposure (the D2P
association). The snippet carries no frequency content, so the FREQUENT
band is a documented clinical estimate consistent with headache being
listed first among the nonspecific initial symptoms
(docs/frequency-evidence-guidelines.md, Pattern D) rather than a value
extracted from the citation.
- category: Nervous System
name: Dizziness
description: >-
Dizziness and lightheadedness are common early symptoms of CO exposure.
Bound to HP:0002321 (Vertigo) as the closest available HPO term — HPO lacks
a clean generic "dizziness/lightheadedness" concept, so this is a
granularity approximation rather than an assertion of true vertigo.
phenotype_term:
preferred_term: dizziness
term:
id: HP:0002321
label: Vertigo
evidence:
- reference: PMID:26563790
reference_title: "Carbon monoxide intoxication."
supports: SUPPORT
evidence_source: OTHER
snippet: "The initial symptoms with CO exposure when COHb is 15-30% are nonspecific, namely, headache, dizziness, nausea, fatigue, and impaired manual dexterity."
explanation: Supports dizziness as a common early symptom of CO exposure.
- category: Gastrointestinal
name: Nausea and vomiting
description: >-
Nausea and vomiting are common nonspecific symptoms of acute CO poisoning,
often mistaken for gastroenteritis.
phenotype_term:
preferred_term: nausea and vomiting
term:
id: HP:0002017
label: Nausea and vomiting
evidence:
- reference: PMID:35461624
reference_title: "Carbon Monoxide Toxicity."
supports: SUPPORT
evidence_source: OTHER
snippet: "Clinical effects can be diverse and include headache, dizziness, nausea, vomiting, syncope, seizures, coma, dysrhythmias, and cardiac ischemia, and severe toxicity generally affects the nervous and cardiovascular systems."
explanation: Supports nausea and vomiting as clinical effects of CO poisoning.
- category: Constitutional
name: Fatigue
description: >-
Fatigue and malaise are common nonspecific manifestations of CO exposure.
phenotype_term:
preferred_term: fatigue
term:
id: HP:0012378
label: Fatigue
evidence:
- reference: PMID:24518173
reference_title: "Cardiovascular Abnormalities in Carbon Monoxide Poisoning."
supports: SUPPORT
evidence_source: OTHER
snippet: "It manifests as broad spectrum of symptoms ranging from mild headache, nausea, and fatigue to dizziness, syncope, coma, seizures resulting in cardiovascular collapse, respiratory failure, and death."
explanation: Supports fatigue as an early manifestation within the CO poisoning symptom spectrum.
- category: Nervous System
name: Syncope
description: >-
Loss of consciousness or syncope occurs with more severe exposure and is an
indicator of significant poisoning.
phenotype_term:
preferred_term: syncope
term:
id: HP:0001279
label: Syncope
evidence:
- reference: PMID:26563790
reference_title: "Carbon monoxide intoxication."
supports: SUPPORT
evidence_source: OTHER
snippet: "COHb levels between 30% and 70% lead to loss of consciousness and eventually death."
explanation: Supports loss of consciousness/syncope as a marker of severe poisoning.
- category: Nervous System
name: Seizures
description: >-
Seizures can occur in severe acute CO poisoning.
phenotype_term:
preferred_term: seizures
term:
id: HP:0001250
label: Seizure
evidence:
- reference: PMID:35461624
reference_title: "Carbon Monoxide Toxicity."
supports: SUPPORT
evidence_source: OTHER
snippet: "Clinical effects can be diverse and include headache, dizziness, nausea, vomiting, syncope, seizures, coma, dysrhythmias, and cardiac ischemia, and severe toxicity generally affects the nervous and cardiovascular systems."
explanation: Supports seizures as a clinical effect of severe CO poisoning.
- category: Nervous System
name: Coma
description: >-
Coma occurs in severe poisoning and portends risk of death or delayed
neurological sequelae.
phenotype_term:
preferred_term: coma
term:
id: HP:0001259
label: Coma
evidence:
- reference: PMID:27753502
reference_title: "Carbon Monoxide Poisoning: Pathogenesis, Management, and Future Directions of Therapy."
supports: SUPPORT
evidence_source: OTHER
snippet: "The clinical presentation runs a spectrum, ranging from headache and dizziness to coma and death, with a mortality rate ranging from 1 to 3%."
explanation: Supports coma at the severe end of the CO poisoning clinical spectrum.
- category: Nervous System
name: Confusion
description: >-
Confusion and altered mental status are common acute neurobehavioral
manifestations of CO poisoning, distinct from the persistent delayed
cognitive impairment and from frank coma modeled separately.
phenotype_term:
preferred_term: confusion / altered mental status
term:
id: HP:0001289
label: Confusion
evidence:
- reference: PMID:32015960
reference_title: "Carbon monoxide poisoning."
supports: SUPPORT
evidence_source: OTHER
snippet: "Since behavioral disorders such as agitation, confusion and hallucination are sometimes observed"
explanation: Supports confusion/altered mental status as an acute neurobehavioral manifestation of CO poisoning.
- category: Nervous System
name: Cognitive impairment
frequency: FREQUENT
description: >-
Persistent or delayed cognitive impairment is a hallmark of delayed
neuropsychiatric sequelae following CO poisoning, occurring in a substantial
minority of patients.
phenotype_term:
preferred_term: cognitive impairment
term:
id: HP:0100543
label: Cognitive impairment
evidence:
- reference: PMID:27753502
reference_title: "Carbon Monoxide Poisoning: Pathogenesis, Management, and Future Directions of Therapy."
supports: SUPPORT
evidence_source: OTHER
snippet: "Long-term neurocognitive deficits occur in 15-40% of patients, whereas approximately one-third of moderate to severely poisoned patients exhibit cardiac dysfunction, including arrhythmia, left ventricular systolic dysfunction, and myocardial infarction."
explanation: >-
Supports long-term neurocognitive deficits in a substantial fraction of
patients. The reported 15-40% range straddles the OCCASIONAL (5-29%) and
FREQUENT (30-79%) boundary; FREQUENT is banded on the upper end of the
range, consistent with the cited review treating long-term neurocognitive
deficit as a hallmark sequela rather than an uncommon outcome. The lower
end of the reported range would band as OCCASIONAL.
- category: Nervous System
name: Memory impairment
description: >-
Memory deficits are among the most frequent delayed neuropsychiatric
sequelae after CO poisoning.
phenotype_term:
preferred_term: memory impairment
term:
id: HP:0002354
label: Memory impairment
evidence:
- reference: PMID:26563790
reference_title: "Carbon monoxide intoxication."
supports: SUPPORT
evidence_source: OTHER
snippet: "Following resolution of acute symptoms there may be a lucid interval of 2-40 days before the development of delayed neurologic sequelae (DNS), with diffuse demyelination in the brain accompanied by lethargy, behavior changes, forgetfulness, memory loss, and parkinsonian features."
explanation: Supports memory loss as a delayed neuropsychiatric sequela of CO poisoning.
- category: Nervous System
name: Parkinsonism
description: >-
Delayed parkinsonism and other movement disorders can follow CO poisoning,
associated with basal-ganglia (globus pallidus) injury.
phenotype_term:
preferred_term: parkinsonism
term:
id: HP:0001300
label: Parkinsonism
evidence:
- reference: PMID:26563790
reference_title: "Carbon monoxide intoxication."
supports: SUPPORT
evidence_source: OTHER
snippet: "Following resolution of acute symptoms there may be a lucid interval of 2-40 days before the development of delayed neurologic sequelae (DNS), with diffuse demyelination in the brain accompanied by lethargy, behavior changes, forgetfulness, memory loss, and parkinsonian features."
explanation: Supports parkinsonian features as a delayed neuropsychiatric sequela of CO poisoning.
- category: Cardiovascular
name: Myocardial injury
frequency: OCCASIONAL
description: >-
Myocardial ischemia and injury — including myocardial infarction, myocardial
stunning, left ventricular dysfunction, and arrhythmia — occur in
moderate-to-severe CO poisoning and predict worse outcomes.
phenotype_term:
preferred_term: myocardial infarction
term:
id: HP:0001658
label: Myocardial infarction
evidence:
- reference: PMID:27753502
reference_title: "Carbon Monoxide Poisoning: Pathogenesis, Management, and Future Directions of Therapy."
supports: SUPPORT
evidence_source: OTHER
snippet: "Long-term neurocognitive deficits occur in 15-40% of patients, whereas approximately one-third of moderate to severely poisoned patients exhibit cardiac dysfunction, including arrhythmia, left ventricular systolic dysfunction, and myocardial infarction."
explanation: >-
Supports myocardial injury and cardiac dysfunction in roughly one-third of
moderate-to-severe cases. The OCCASIONAL band departs downward from that
figure deliberately: the one-third denominator is the moderate-to-severely
poisoned subgroup, not all CO-poisoned patients, and that subgroup is a
minority of presentations, so the share of the whole disease population
falls in the OCCASIONAL range (5-29%) rather than FREQUENT (30-79%).
- category: Cardiovascular
name: Chest pain
description: >-
Chest pain can accompany CO-induced myocardial ischemia, especially in
individuals with underlying ischemic heart disease.
phenotype_term:
preferred_term: chest pain
term:
id: HP:0100749
label: Chest pain
evidence:
- reference: PMID:26563790
reference_title: "Carbon monoxide intoxication."
supports: SUPPORT
evidence_source: OTHER
snippet: "individuals with ischemic heart disease may experience chest pain and decreased exercise duration at COHb levels between 1% and 9%."
explanation: Supports chest pain from myocardial ischemia at low COHb levels in susceptible individuals.
- category: Respiratory
name: Respiratory failure
description: >-
Severe CO poisoning can progress to respiratory failure, sometimes with
noncardiogenic pulmonary edema.
phenotype_term:
preferred_term: respiratory failure
term:
id: HP:0002878
label: Respiratory failure
evidence:
- reference: PMID:24518173
reference_title: "Cardiovascular Abnormalities in Carbon Monoxide Poisoning."
supports: SUPPORT
evidence_source: OTHER
snippet: "It manifests as broad spectrum of symptoms ranging from mild headache, nausea, and fatigue to dizziness, syncope, coma, seizures resulting in cardiovascular collapse, respiratory failure, and death."
explanation: Supports respiratory failure at the severe end of the CO poisoning spectrum.
histopathology:
- name: Bilateral globus pallidus lesions
description: >-
Neuroimaging and pathology in CO poisoning characteristically show bilateral,
symmetric lesions of the globus pallidus and diffuse white-matter injury,
the signature central-nervous-system lesion of the disease.
context: Brain MRI/pathology following carbon monoxide poisoning
diagnostic: false
evidence:
- reference: PMID:26563790
reference_title: "Carbon monoxide intoxication."
supports: SUPPORT
evidence_source: OTHER
snippet: "White-matter damage in the centrum semiovale and periventricular area and abnormalities in the globus pallidus are most commonly seen on MRI following CO exposure."
explanation: Supports the globus pallidus and white-matter lesions as the characteristic imaging/pathology finding.
notes: >-
Basal ganglia/globus pallidus lesions are characteristic but their reported
prevalence varies widely and they may be less common than historically stated.
biochemical:
- name: Carboxyhemoglobin
presence: INCREASED
notes: >-
Elevated blood carboxyhemoglobin (COHb), measured by co-oximetry, confirms
CO exposure. Standard pulse oximetry cannot distinguish oxyhemoglobin from
carboxyhemoglobin and reads falsely normal. COHb magnitude correlates
imperfectly with clinical severity.
evidence:
- reference: PMID:34053712
reference_title: "Carbon Monoxide Poisoning."
supports: SUPPORT
evidence_source: OTHER
snippet: "When there is concern for possible carbon monoxide poisoning, the diagnosis can be made via blood co-oximetry."
explanation: Supports blood carboxyhemoglobin by co-oximetry as the confirmatory biomarker.
- name: Lactate
presence: INCREASED
notes: >-
Elevated serum lactate reflects impaired oxidative metabolism and metabolic
acidosis, and is used as a marker of severity.
environmental:
- name: Faulty heating appliances
exposure_term:
preferred_term: exposure to carbon monoxide
term:
id: ECTO:0000207
label: exposure to carbon monoxide
description: >-
Malfunctioning or improperly ventilated furnaces, boilers, water heaters,
and space heaters are a leading source of unintentional CO poisoning,
especially in cold weather.
evidence:
- reference: PMID:32015960
reference_title: "Carbon monoxide poisoning."
supports: SUPPORT
evidence_source: OTHER
snippet: "Vehicle exhaust, smoke from fires and improperly maintained heating systems are included as common sources."
explanation: Supports improperly maintained heating systems as a common exposure source.
influences_mechanisms:
- target: Carboxyhemoglobin formation
environmental_effect: TRIGGERS
causal_link_type: DIRECT
description: >-
A malfunctioning or unvented appliance releases carbon monoxide into
occupied indoor air, where it is inhaled and binds hemoglobin.
evidence:
- reference: PMID:26563790
reference_title: "Carbon monoxide intoxication."
supports: SUPPORT
evidence_source: OTHER
snippet: "Once CO is inhaled it binds with hemoglobin to form carboxyhemoglobin (COHb) with an affinity 200 times greater than oxygen that leads to decreased oxygen-carrying capacity and decreased release of oxygen to tissues leading to tissue hypoxia."
explanation: >-
Inhaled carbon monoxide binds hemoglobin to form carboxyhemoglobin, the
step this source feeds; the four combustion sources differ in where the
CO comes from, not in how it is taken up.
- name: Fire smoke inhalation
exposure_term:
preferred_term: exposure to carbon monoxide
term:
id: ECTO:0000207
label: exposure to carbon monoxide
description: >-
Smoke from structure fires contains high concentrations of CO and is a major
cause of CO poisoning in fire victims.
evidence:
- reference: PMID:32015960
reference_title: "Carbon monoxide poisoning."
supports: SUPPORT
evidence_source: OTHER
snippet: "Vehicle exhaust, smoke from fires and improperly maintained heating systems are included as common sources."
explanation: Supports smoke from fires as a common exposure source.
influences_mechanisms:
- target: Carboxyhemoglobin formation
environmental_effect: TRIGGERS
causal_link_type: DIRECT
description: >-
Structure-fire smoke carries high concentrations of carbon monoxide,
which victims inhale directly at the scene.
evidence:
- reference: PMID:26563790
reference_title: "Carbon monoxide intoxication."
supports: SUPPORT
evidence_source: OTHER
snippet: "Once CO is inhaled it binds with hemoglobin to form carboxyhemoglobin (COHb) with an affinity 200 times greater than oxygen that leads to decreased oxygen-carrying capacity and decreased release of oxygen to tissues leading to tissue hypoxia."
explanation: >-
Inhaled carbon monoxide binds hemoglobin to form carboxyhemoglobin, the
step this source feeds; the four combustion sources differ in where the
CO comes from, not in how it is taken up.
- name: Motor vehicle exhaust
exposure_term:
preferred_term: exposure to carbon monoxide
term:
id: ECTO:0000207
label: exposure to carbon monoxide
environment_context:
preferred_term: gasoline exhaust
term:
id: ENVO:03510009
label: gasoline exhaust
description: >-
Engine exhaust from motor vehicles, including running vehicles in enclosed
spaces, is a common source of both accidental and intentional CO poisoning.
evidence:
- reference: PMID:32015960
reference_title: "Carbon monoxide poisoning."
supports: SUPPORT
evidence_source: OTHER
snippet: "Vehicle exhaust, smoke from fires and improperly maintained heating systems are included as common sources."
explanation: Supports vehicle exhaust as a common exposure source.
influences_mechanisms:
- target: Carboxyhemoglobin formation
environmental_effect: TRIGGERS
causal_link_type: DIRECT
description: >-
Engine exhaust in an enclosed space accumulates carbon monoxide to
inhaled concentrations far above those the ambient air would give.
evidence:
- reference: PMID:26563790
reference_title: "Carbon monoxide intoxication."
supports: SUPPORT
evidence_source: OTHER
snippet: "Once CO is inhaled it binds with hemoglobin to form carboxyhemoglobin (COHb) with an affinity 200 times greater than oxygen that leads to decreased oxygen-carrying capacity and decreased release of oxygen to tissues leading to tissue hypoxia."
explanation: >-
Inhaled carbon monoxide binds hemoglobin to form carboxyhemoglobin, the
step this source feeds; the four combustion sources differ in where the
CO comes from, not in how it is taken up.
- name: Portable generators and indoor combustion
exposure_term:
preferred_term: exposure to carbon monoxide
term:
id: ECTO:0000207
label: exposure to carbon monoxide
description: >-
Portable gasoline generators, charcoal grills, and other fuel-burning
devices used indoors or in poorly ventilated spaces are important sources of
CO poisoning, notably during power outages after storms.
evidence:
- reference: PMID:26563790
reference_title: "Carbon monoxide intoxication."
supports: SUPPORT
evidence_source: OTHER
snippet: "gasoline-powered generators that are not in correct locations"
explanation: Supports improperly located gasoline-powered generators as an exposure source.
influences_mechanisms:
- target: Carboxyhemoglobin formation
environmental_effect: TRIGGERS
causal_link_type: DIRECT
description: >-
Fuel-burning devices run indoors or in poorly ventilated spaces vent
carbon monoxide into breathing air rather than outdoors.
evidence:
- reference: PMID:26563790
reference_title: "Carbon monoxide intoxication."
supports: SUPPORT
evidence_source: OTHER
snippet: "Once CO is inhaled it binds with hemoglobin to form carboxyhemoglobin (COHb) with an affinity 200 times greater than oxygen that leads to decreased oxygen-carrying capacity and decreased release of oxygen to tissues leading to tissue hypoxia."
explanation: >-
Inhaled carbon monoxide binds hemoglobin to form carboxyhemoglobin, the
step this source feeds; the four combustion sources differ in where the
CO comes from, not in how it is taken up.
- name: Methylene chloride exposure
exposure_term:
preferred_term: exposure to carbon monoxide
term:
id: ECTO:0000207
label: exposure to carbon monoxide
description: >-
Inhaled methylene chloride (dichloromethane), used in paint strippers and
solvents, is metabolized in the liver to carbon monoxide, raising
carboxyhemoglobin; high-dose exposure can produce delayed and prolonged CO
toxicity from this endogenous source.
evidence:
- reference: PMID:8925320
reference_title: "Carboxyhemoglobin levels in methylene chloride-exposed employees."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Part of the rationale for lowering the standard is a concern over potentially adverse cardiac effects secondary to elevated carboxyhemoglobin (COHb) levels as a by-product of methylene chloride metabolism."
explanation: Supports methylene chloride metabolism to carbon monoxide raising carboxyhemoglobin.
influences_mechanisms:
- target: Carboxyhemoglobin formation
environmental_effect: TRIGGERS
causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
description: >-
Unlike the combustion sources, no carbon monoxide is inhaled here: the
inhaled solvent is metabolized by hepatic CYP2E1 to carbon monoxide, so
the carboxyhemoglobin arises from an endogenous source. That extra step is
why the rise is delayed and prolonged relative to a direct CO exposure.
evidence:
- reference: PMID:8925320
reference_title: "Carboxyhemoglobin levels in methylene chloride-exposed employees."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Part of the rationale for lowering the standard is a concern over potentially adverse cardiac effects secondary to elevated carboxyhemoglobin (COHb) levels as a by-product of methylene chloride metabolism."
explanation: >-
Names carboxyhemoglobin as a by-product of methylene chloride
metabolism, establishing metabolism as the intermediate between the
solvent exposure and the carboxyhemoglobin it produces.
treatments:
- name: Normobaric high-flow oxygen
description: >-
High-concentration oxygen delivered at normal atmospheric pressure is the
first-line treatment. It accelerates dissociation of CO from hemoglobin,
shortening the elimination half-life of carboxyhemoglobin from several hours
on room air to roughly 60-90 minutes. It is usually delivered via a
non-rebreather mask.
treatment_term:
preferred_term: supplemental oxygen therapy
term:
id: NCIT:C94624
label: Oxygen Therapy
target_mechanisms:
- target: Carboxyhemoglobin formation
treatment_effect: INHIBITS
description: Oxygen competes CO off hemoglobin and speeds carboxyhemoglobin elimination.
evidence:
- reference: PMID:26563790
reference_title: "Carbon monoxide intoxication."
supports: SUPPORT
evidence_source: OTHER
snippet: "The cornerstone for treatment for CO poisoning is 100% oxygen using a tight-fitting mask for greater than 6 hours."
explanation: Supports 100% oxygen therapy as the intervention that accelerates carboxyhemoglobin clearance.
evidence:
- reference: PMID:34053712
reference_title: "Carbon Monoxide Poisoning."
supports: SUPPORT
evidence_source: OTHER
snippet: "The primary treatment for patients with carbon monoxide poisoning is supplemental oxygen, usually delivered via a nonrebreather mask."
explanation: Supports supplemental (normobaric) oxygen as the primary treatment.
- reference: PMID:26563790
reference_title: "Carbon monoxide intoxication."
supports: SUPPORT
evidence_source: OTHER
snippet: "The cornerstone for treatment for CO poisoning is 100% oxygen using a tight-fitting mask for greater than 6 hours."
explanation: Supports 100% oxygen as the cornerstone of therapy.
- name: Hyperbaric oxygen therapy
description: >-
Hyperbaric oxygen delivered at greater than atmospheric pressure further
accelerates carboxyhemoglobin elimination, increases dissolved plasma oxygen,
and is proposed to reduce delayed neurological sequelae. It is considered for
severe poisoning, loss of consciousness, neurological deficits, myocardial
ischemia, or pregnancy, though its exact indications remain debated.
treatment_term:
preferred_term: hyperbaric oxygen therapy
term:
id: NCIT:C38065
label: Hyperbaric Oxygen Therapy
target_mechanisms:
- target: Carboxyhemoglobin formation
treatment_effect: INHIBITS
description: Hyperbaric pressure maximally accelerates CO displacement from hemoglobin.
evidence:
- reference: PMID:26563790
reference_title: "Carbon monoxide intoxication."
supports: SUPPORT
evidence_source: OTHER
snippet: "The indications for treatment with hyperbaric oxygen to decrease the half-life of COHb remain controversial."
explanation: Supports hyperbaric oxygen acting to decrease the carboxyhemoglobin half-life.
- target: Platelet-neutrophil activation
treatment_effect: INHIBITS
description: Hyperbaric oxygen inhibits CD18-mediated neutrophil adhesion, interrupting the oxidative-inflammatory cascade proposed to drive delayed neurological injury.
evidence:
- reference: PMID:7710151
reference_title: "Delayed neuropsychologic sequelae after carbon monoxide poisoning: prevention by treatment with hyperbaric oxygen."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "HBO treatment decreased the incidence of DNS after CO poisoning."
explanation: Supports hyperbaric oxygen reducing delayed neurological sequelae, the clinical outcome of the neuroinflammatory cascade.
evidence:
- reference: PMID:12362006
reference_title: "Hyperbaric oxygen for acute carbon monoxide poisoning."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Cognitive sequelae at six weeks were less frequent in the hyperbaric-oxygen group"
explanation: Randomized-trial evidence that hyperbaric oxygen reduces cognitive sequelae.
- reference: PMID:7710151
reference_title: "Delayed neuropsychologic sequelae after carbon monoxide poisoning: prevention by treatment with hyperbaric oxygen."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "HBO treatment decreased the incidence of DNS after CO poisoning."
explanation: Randomized-trial evidence that hyperbaric oxygen reduces delayed neurological sequelae.
- reference: PMID:34053712
reference_title: "Carbon Monoxide Poisoning."
supports: SUPPORT
evidence_source: OTHER
snippet: "Hyperbaric oxygen can also be used, but the exact indications are controversial."
explanation: Notes that hyperbaric oxygen is used but its indications remain controversial.
- name: Exposure removal and supportive care
description: >-
Immediate removal from the CO source and supportive care, including airway
management, cardiac monitoring, and hemodynamic support, are essential first
steps.
treatment_term:
preferred_term: supportive care
term:
id: NCIT:C15747
label: Supportive Care
target_mechanisms:
- target: Carboxyhemoglobin formation
treatment_effect: INHIBITS
description: Removing the patient from the source halts ongoing CO uptake.
discussions:
- discussion_id: gap_co_hbo_patient_selection
prompt: >-
Which carbon monoxide poisoning patients derive a durable neurological
benefit from hyperbaric oxygen therapy, and by what mechanism?
kind: KNOWLEDGE_GAP
status: OPEN
attaches_to:
- treatments#Hyperbaric oxygen therapy
- pathophysiology#Delayed neuronal injury
rationale: >-
Randomized trials conflict. Thom 1995 and Weaver 2002 found that hyperbaric
oxygen reduced delayed/cognitive sequelae, whereas Scheinkestel 1999 found
no benefit and even worse outcomes on some measures, using a different
protocol and patient mix. The subset of patients who benefit, the optimal
timing and pressure, and whether the benefit comes from faster CO clearance
or from interrupting the immune-mediated demyelination cascade remain
unresolved.
evidence:
- reference: PMID:10092916
reference_title: "Hyperbaric or normobaric oxygen for acute carbon monoxide poisoning: a randomised controlled clinical trial."
supports: REFUTE
evidence_source: HUMAN_CLINICAL
snippet: "HBO patients had a worse outcome in the learning test at completion of treatment (P = 0.01 for all patients; P = 0.005 for severely poisoned patients)"
explanation: Provides the negative-trial evidence that motivates the open question about which patients benefit from hyperbaric oxygen.
- discussion_id: mismatch_co_rodent_mbp_autoimmunity
prompt: >-
Does the rodent anti-myelin-basic-protein autoimmune mechanism of delayed
neuropathology quantitatively explain human delayed neurological sequelae?
kind: HUMAN_MODEL_MISMATCH
status: OPEN
attaches_to:
- pathophysiology#Immune-mediated neuroinflammation
- pathophysiology#Delayed demyelination
rationale: >-
The adaptive-immune, anti-MBP mechanism of delayed CO neuropathology is
established chiefly in rats, where immunological tolerance to MBP before
poisoning abolishes the learning deficit, demonstrating causation. Its
quantitative fidelity to human delayed neurological sequelae is not
established; human delayed encephalopathy is heterogeneous and the
contribution of MBP autoimmunity relative to hypoxic-ischemic injury in
people remains an open translational question.
evidence:
- reference: PMID:15342916
reference_title: "Delayed neuropathology after carbon monoxide poisoning is immune-mediated."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "These results demonstrate that delayed CO-mediated neuropathology is linked to an adaptive immunological response to chemically modified MBP."
explanation: Establishes the immune-mediated mechanism in the rat model whose translational validity to humans is the open question.
datasets:
- accession: geo:GSE94780
title: Gene expression in rat striatum following carbon monoxide poisoning and hypoxic hypoxia
description: We have proposed the existence of a threshold for brain damage, in terms of hydroxyl radical production in rat striatum, between poisoning of carbon monoxide (CO) at 1000 ppm and 3000 ppm, where blood CO-hemoglobin levels reach approximately 50% and over 70%, respectively. To search for factors involved in brain damage, we examined the effects of air, 1000 ppm CO, 3000 ppm CO and 5% O2 (hypoxic conditions comparable with those by 3000 ppm CO) on gene expression in rat striatum, using microarray analysis.
organism:
preferred_term: rat
term:
id: NCBITaxon:10116
label: Rattus norvegicus
data_type: MICROARRAY
sample_count: 12
notes: Identified by GEO DataSets index search for Carbon Monoxide Poisoning (scripts/discover_datasets.py); accession and metadata verified against NCBI E-utilities on 2026-08-01. Title, sample count, and organism are GEO's own values.
Prepared for: dismech disease knowledge base entry Category: Environmental (toxic gas exposure) Report date: 2026-07-09
Scope note: Carbon monoxide (CO) poisoning is a toxic-exposure syndrome, not a Mendelian or genetically-defined disease. Sections framed around causal genes, inheritance, penetrance, founder effects, and germline variants are largely Not Applicable; they are retained below with explicit "N/A" annotations and repurposed toward host susceptibility modifiers where evidence exists. The mechanistic, phenotypic, diagnostic, treatment, and prevention sections are the substantive core.
Overview. Carbon monoxide poisoning is the clinical syndrome resulting from inhalation of carbon monoxide, a colorless, odorless, tasteless, non-irritating gas produced by incomplete combustion of carbon-containing (hydrocarbon) fuels. It is one of the most common causes of fatal poisoning worldwide. CO produces injury through two convergent mechanisms: (1) hypoxic stress from formation of carboxyhemoglobin (COHb), which reduces oxygen-carrying capacity and shifts the oxyhemoglobin dissociation curve leftward (impairing tissue oxygen offloading); and (2) direct cellular toxicity independent of COHb — binding to mitochondrial cytochrome c oxidase, myoglobin, and other heme proteins, plus oxidative/nitrosative stress and an immune-mediated delayed neuroinflammatory cascade (StatPearls Carboxyhemoglobin Toxicity, NBK557888; Weaver, NEJM 2002, PMID 12362006).
Key identifiers.
- MONDO: MONDO:0021113 (carbon monoxide poisoning) — verify against the local sqlite:obo:mondo adapter before committing (runoak -i sqlite:obo:mondo info MONDO:0021113 -O obo); OLS did not render the record in this session, so treat the ID as provisional. A closely related concept is carboxyhemoglobinemia.
- ICD-10-CM: T58.- "Toxic effect of carbon monoxide," with source/intent subcodes — e.g., T58.01XA (motor-vehicle exhaust, accidental, initial encounter), T58.11XA (utility gas, accidental), T58.91XA (unspecified source, accidental), and intentional-self-harm variants (T58.-2-).
- ICD-11: NE61 / stem for toxic effect of carbon monoxide (foundation "Toxic effect of carbon monoxide").
- MeSH: D002249 "Carbon Monoxide Poisoning."
- OMIM/Orphanet: No dedicated Mendelian OMIM entry (not a genetic disease). Not a designated rare disease in Orphanet.
- SNOMED CT: 284196006 "Carbon monoxide poisoning" (concept present; verify current ID).
Synonyms / alternative names. CO poisoning; carbon monoxide toxicity; carbon monoxide intoxication; carboxyhemoglobinemia (the biochemical state); "silent killer" (lay). Historically overlapping legacy terms: "coal gas poisoning," "flue gas / smoke inhalation CO component."
Data derivation. Disease-level knowledge here derives from aggregated resources (CDC/WHO surveillance, poison-center data, UHMS/society guidelines, and clinical-trial cohorts) rather than individual EHR records, though large administrative/EHR and forensic cohorts underpin the epidemiology and prognosis figures.
Sources: StatPearls Carboxyhemoglobin Toxicity; MSD/Merck Manual; ICD10Data T58.
Primary cause (environmental/toxic). Inhalation of CO gas. There is no genetic or infectious primary etiology — this is a pure environmental/toxicological exposure disease. CHEBI: carbon monoxide = CHEBI:17245.
Common exposure sources.
- Faulty or unvented fuel-burning appliances: furnaces, gas/oil boilers, water heaters, gas ranges/ovens, space heaters.
- Motor-vehicle exhaust (running engines in attached/closed garages; a frequent suicide method).
- Portable generators, a major cause of poisoning and death during storm-related power outages (CDC disaster guidance).
- Charcoal grills / hibachis used indoors; camping stoves and lanterns in tents.
- House fires / smoke inhalation (CO is a leading cause of fire-related death).
- Methylene chloride (dichloromethane, CHEBI:15767) — paint strippers and solvents; hepatically metabolized to CO, causing delayed, prolonged COHb elevation.
- Indoor use of gasoline-powered tools; ice-rink resurfacers; boating "houseboat/exhaust" exposures.
- Tobacco/hookah smoke (chronic low-level source; baseline COHb 3–10% in smokers).
Risk factors (environmental / demographic). - Season: winter months (heating use); poisonings and deaths peak in cold months (CDC/NVSS). - Setting: most exposures occur at home; disasters and power outages (generators). - Sex: male death rate ~0.22/100,000 vs female ~0.07/100,000 (>3× higher in males, 1999–2010 CDC data) — partly reflecting occupational exposure and intentional poisoning. - Age: highest death rates in adults ≥65 years (males 0.42, females 0.18 per 100,000). - Occupation: firefighters, garage/toll workers, welders, mechanics, foundry/blast-furnace workers, propane forklift operators. - Pregnancy: enhanced fetal vulnerability (see §9, §12). - Comorbidity: pre-existing coronary artery disease, anemia, chronic respiratory disease, and cerebrovascular disease increase susceptibility to a given COHb level. - Absent CO detectors in the home is a strong, modifiable risk factor for fatal poisoning (Yoon, JAMA 1998, PMID 9496987).
Genetic / host-susceptibility modifiers (not causal). True Mendelian causation is N/A. Reported modifiers of susceptibility or of delayed neurological sequelae (DNS) are limited and largely candidate-gene/observational: haptoglobin phenotype, HMOX1 (heme oxygenase-1) promoter (GT)n repeat polymorphisms, apolipoprotein E (APOE) genotype, and inflammatory-cytokine polymorphisms have been proposed to modulate outcome, but none are established. Individuals with higher baseline COHb (smokers), anemia (lower total O₂-carrying reserve), or cardiac/cerebrovascular disease tolerate less CO.
Protective factors. - CO detectors/alarms (primary environmental protection; legislative mandates reduce deaths). - Appliance maintenance, adequate ventilation, and never running engines/generators indoors. - No established genetic protective variant.
Gene–environment interaction. The dose–response to a fixed CO exposure is modulated by host oxygen-carrying reserve and antioxidant/inflammatory genotype (e.g., HMOX1, antioxidant enzymes), but this remains hypothesis-level (CTD lists CO–gene interactions primarily from toxicogenomic models, not clinical GxE). Treat as an open knowledge gap (KNOWLEDGE_GAP).
Sources: CDC QuickStats 1999–2010; Yoon 1998 PMID 9496987; CDC disaster clinical guidance.
CO poisoning is a multisystem syndrome with nonspecific early symptoms (often misdiagnosed as viral illness or food poisoning). Manifestations correlate imperfectly with COHb level; clinical severity, duration of exposure, and host factors matter more than a single COHb number.
Neurologic / neuropsychiatric (dominant and prognostically important). - Headache — the most common early symptom (often "dull, frontal"). HPO: Headache HP:0002315. Frequency: very frequent/most common. - Dizziness / lightheadedness — HPO: Vertigo HP:0002321 / Dizziness. Frequent. - Confusion, impaired cognition, difficulty concentrating — HPO: Confusion HP:0001289; Cognitive impairment HP:0100543. Frequent-to-severe cases. - Syncope / loss of consciousness — HPO: Syncope HP:0001279; Loss of consciousness HP:0007185. A key severity marker and HBO indication. - Seizures — HPO: Seizure HP:0001250. Severe poisoning. - Coma — HPO: Reduced consciousness/confusion → Coma HP:0001259. Severe. - Delayed neurological/neuropsychiatric sequelae (DNS / DEACMP) — a hallmark: after apparent recovery, a lucid interval of days–weeks precedes cognitive decline, memory loss, parkinsonism, gait/movement disorders, personality/affective change, incontinence, and akinetic mutism. HPO overlaps: Parkinsonism HP:0001300, Memory impairment HP:0002354, Gait disturbance HP:0001288, Personality changes HP:0000751, Dystonia HP:0001332. Onset typically 2–40 days post-recovery; occurs in ~3–40% depending on severity/definition. - Peripheral neuropathy, hearing loss, vestibular dysfunction (less common).
Cardiovascular. - Myocardial ischemia / injury — chest pain, ECG ischemia, troponin rise, arrhythmia; myocardial infarction with angiographically normal coronaries possible. HPO: Myocardial infarction HP:0001658; Angina pectoris HP:0001681; Arrhythmia HP:0011675. Common in moderate–severe poisoning; associated with increased long-term mortality. - Hypotension, tachycardia.
Respiratory. - Dyspnea (HPO: Dyspnea HP:0002094), tachypnea; noncardiogenic pulmonary edema in severe cases.
General / constitutional. - Nausea and vomiting — HPO: Nausea and vomiting HP:0002017 (or Nausea HP:0002018 / Vomiting HP:0002013). Frequent; often mistaken for gastroenteritis. - Fatigue / weakness / malaise — HPO: Fatigue HP:0012378; Muscle weakness HP:0001324. - Visual disturbance / blurred vision — HPO: Blurred vision HP:0000622; rarely retinal hemorrhages, cortical blindness.
Dermatologic. - The classically taught "cherry-red" skin/lips is rare and unreliable (usually a postmortem finding); cyanosis or normal color is more typical. Bullous skin lesions/pressure necrosis can occur in comatose patients.
Laboratory abnormalities (phenotype: laboratory). - Elevated carboxyhemoglobin (COHb) — the defining lab abnormality. Normal <3% (nonsmokers), up to ~10–15% in heavy smokers. Symptomatic poisoning usually >10–20%. LOINC: COHb/Hb.total — LOINC 20563-3 (Carboxyhemoglobin/Hemoglobin.total in Blood). - Metabolic acidosis with elevated lactate (anaerobic metabolism) — LOINC: Lactate 2524-7; a severity marker. - Elevated cardiac troponin / CK-MB (myocardial injury). - Elevated creatine kinase ± rhabdomyolysis/AKI in immobilized/comatose patients. - Falsely normal SpO₂ on standard pulse oximetry — conventional oximeters cannot distinguish COHb from oxyhemoglobin ("saturation gap"); requires CO-oximetry (multi-wavelength). A critical diagnostic pitfall.
Quality-of-life impact. Survivors of moderate–severe poisoning, especially those developing DNS, may have persistent cognitive deficits, mood/anxiety disorders, chronic headache, and impaired executive function, with measurable declines on neuropsychological batteries and quality-of-life instruments; some do not fully recover by 12 months (Weaver, NEJM 2002). Chronic low-level exposure produces persistent headache, fatigue, and cognitive complaints.
Onset/severity/progression summary. Onset acute (minutes–hours of exposure); severity mild → severe/fatal and variable; a distinct biphasic course is possible (acute illness → apparent recovery → DNS). Symptom–COHb correlation is weak.
Sources: Merck Manual; MedLink Neurology; Weaver NEJM 2002 PMID 12362006.
Causal genes: None — Not Applicable. CO poisoning is a toxic exposure, not a Mendelian disorder. There are no causal genes, pathogenic variants (ACMG/AMP classes), allele frequencies, somatic/germline distinctions, or chromosomal abnormalities to report.
Molecular target of the toxicant (the meaningful "molecular" content). The pathogenic ligand is CO gas (CHEBI:17245), which binds ferrous (Fe²⁺) heme iron in multiple hemoproteins: - Hemoglobin (HBB/HBA) → carboxyhemoglobin. CO affinity ~200–250× that of O₂ (StatPearls cites ~240×). - Myoglobin (MB, HGNC gene MB) → carboxymyoglobin, impairing cardiac and skeletal muscle O₂ storage/utilization; contributes to myocardial dysfunction. - Cytochrome c oxidase (Complex IV, MT-CO1/2/3 + nuclear COX subunits) → inhibition of mitochondrial electron transport and oxidative phosphorylation (direct histotoxic hypoxia). - NADPH oxidase, cytochrome P450, guanylate cyclase, and NOS-associated hemes are additional CO targets influencing signaling and reactive-species production.
Modifier genes / epigenetics / chromosomal: No established modifiers (see §2 for candidate host modifiers such as HMOX1, APOE). Epigenetic and chromosomal sections are N/A for causation. (Note that CO is itself an endogenous signaling molecule generated by heme oxygenase-1, HMOX1, HGNC:5013 — biologically relevant context, not a disease gene.)
Sources: StatPearls NBK557888; ROS/oxidative-stress review PMID 24773392.
Sources: CDC CO topic; Merck Manual.
CO injures tissue through two integrated arms — impaired oxygen delivery/utilization (hypoxic-ischemic) and direct cellular toxicity with oxidative/nitrosative stress and delayed immune-mediated neuroinflammation. The brain and heart, with the highest oxygen demand, are most vulnerable.
A. Hypoxic-ischemic arm. 1. Inhaled CO diffuses across the alveolar–capillary membrane and binds hemoglobin Fe²⁺ → carboxyhemoglobin, reducing O₂-carrying capacity. 2. CO binding to one heme shifts the oxyhemoglobin dissociation curve leftward, further impairing O₂ release to tissue (functional anemia worse than simple loss of capacity). 3. → Tissue hypoxia, anaerobic metabolism, lactic acidosis (GO: cellular response to hypoxia GO:0071456; anaerobic respiration).
B. Direct cytotoxic / histotoxic arm (COHb-independent). 4. CO binds cytochrome c oxidase (Complex IV), inhibiting mitochondrial electron transport and ATP synthesis → histotoxic hypoxia even where O₂ is available (GO: mitochondrial electron transport, cytochrome c to oxygen GO:0006123; oxidative phosphorylation GO:0006119). CO also binds myoglobin → impaired cardiac oxygen utilization → myocardial depression, hypotension, and secondary global ischemia/reperfusion.
C. Oxidative/nitrosative stress and vascular arm. 5. CO displaces nitric oxide (NO) from platelets and hemoproteins → excess NO → peroxynitrite formation; NO/peroxynitrite drive leukocyte (neutrophil) adhesion to injured cerebral microvascular endothelium (β2-integrin–mediated). 6. Adherent neutrophils release myeloperoxidase, generating reactive oxygen species (ROS). ROS are produced from three temporally distinct sources: mitochondria (first minutes of exposure), xanthine oxidase (~20 min, from energy deprivation/purine catabolism), and NADPH oxidase during the post-exposure reoxygenation period — i.e., an ischemia–reperfusion–like injury (Chang et al., ROS review PMID 24773392; PMC9852609). GO: reactive oxygen species metabolic process GO:0072593; response to oxidative stress GO:0006979. 7. → Lipid peroxidation of membrane and myelin lipids; glutathione depletion (GO: lipid oxidation; lipid peroxidation).
D. Delayed immune-mediated demyelination (the DNS engine). 8. Lipid peroxidation generates malondialdehyde (MDA), which forms adducts with myelin basic protein (MBP) in the CNS. Modified MBP loses its normal cationic charge and antibody-recognition profile. 9. Chemically altered MBP is immunogenic: over days, degraded MBP appears in brain with influx of macrophages and CD4⁺ T-lymphocytes, and autoreactive lymphocyte proliferation to MBP develops, with microglial activation → adaptive autoimmune demyelination and delayed neuropathology. Rats made immunologically tolerant to MBP before CO poisoning show the acute biochemical MBP change but no lymphocyte response and no learning deficit, establishing causation (Thom SR et al., PNAS 2004;101(37):13660–13665, PMID 15342916). GO: adaptive immune response GO:0002250; inflammatory response GO:0006954; demyelination. 10. → Delayed neuronal apoptosis (hippocampus, basal ganglia), white-matter demyelination, and DNS.
Cell types involved (CL terms). Neurons (CL:0000540), especially hippocampal neurons and basal-ganglia/globus-pallidus neurons; oligodendrocytes (CL:0000128, myelin) as demyelination targets; microglial cells (CL:0000129); cardiac myocytes (CL:0000746); vascular endothelial cells (CL:0000115); neutrophils (CL:0000775); CD4⁺ T cells (CL:0000624); macrophages (CL:0000235); erythrocytes (CL:0000232, the COHb site).
Subcellular compartments (GO Cellular Component). Mitochondrion (GO:0005739), specifically the mitochondrial respiratory chain complex IV (GO:0005751); myelin sheath (GO:0043209); plasma membrane / cytosol.
Metabolic changes. Shift to anaerobic glycolysis; lactic acidosis; ATP depletion; glutathione depletion; disrupted heme-protein oxygen handling.
Immune involvement. Innate (neutrophil/microglia/macrophage, ROS) acutely; adaptive autoimmune (anti-MBP CD4⁺ T-cell) response driving delayed demyelination — a rare example of a toxic exposure triggering an autoimmune neurologic sequela.
Tissue-damage mechanisms. Oxidative stress, ischemia–reperfusion injury, lipid peroxidation, apoptosis/necrosis, and immune-mediated demyelination converge on the globus pallidus (watershed, high metabolic demand, vulnerable) and deep white matter.
Molecular profiling / advanced tech. Transcriptomic and proteomic studies in rodent DEACMP models show upregulated inflammatory and apoptotic pathways and MBP degradation; candidate serum biomarkers (S100B, NSE, GFAP, myelin-related autoantibodies) have been studied for DNS prediction. Human single-cell/spatial and CRISPR-screen data are not established for this exposure — an open knowledge gap.
Sources: ROS review PMID 24773392; Thom PNAS 2004 PMID 15342916; Mechanism of delayed encephalopathy PMID 32594050; MBP degradation rat PMID 20633582.
Organ level. - Primary: Brain (UBERON:0000955) and heart (UBERON:0000948) — highest O₂ demand. - Secondary / systemic: skeletal muscle (rhabdomyolysis), kidney (UBERON:0002113; AKI from rhabdomyolysis/hypoperfusion), lungs (UBERON:0002048; pulmonary edema), skin, retina/eye, peripheral nerves. - Body systems: nervous, cardiovascular, respiratory, musculoskeletal, and (fetal) reproductive/placental.
Tissue and cell level. - Basal ganglia — especially globus pallidus (UBERON:0001875), the signature CO lesion — and substantia nigra; deep cerebral white matter (UBERON:0002316); hippocampus (UBERON:0002421); cerebral cortex; occasionally putamen, caudate, thalamus (imaging: bilateral, symmetric). - Cell populations: pallidal neurons, hippocampal neurons, oligodendrocytes/myelin, cardiac myocytes, microvascular endothelium.
Subcellular level. Mitochondria (Complex IV) and myelin sheath are the principal molecular battlegrounds.
Localization / laterality. CNS lesions are characteristically bilateral and symmetric (globus pallidus > white matter). On MRI: globus pallidus shows T1 hypo-/T2-FLAIR hyperintensity with restricted diffusion (DWI) acutely; late subacute period shows diffuse white-matter demyelination.
Sources: AJNR Pallidoreticular DWI; Advanced neuroimaging of CO poisoning PMC5602327.
Sources: Weaver NEJM 2002; Predictors of delayed encephalopathy PMC11979149.
Inheritance: Not Applicable (non-genetic exposure). Penetrance, expressivity, anticipation, mosaicism, founder effects, consanguinity, and carrier frequency are all N/A.
Epidemiology (aggregate). - US unintentional mortality: ~430 deaths/year average (1999–2010, total 5,149; CDC); ~2,244 deaths over 2010–2015. In 2022, CDC provisional data recorded 1,244 total CO deaths (624 accidental + 579 suicides). - Morbidity: >100,000 US emergency-department visits/year for accidental CO poisoning, with >14,000 hospitalizations/year (CDC/USAFacts). - Sex ratio: male death rate ~0.22/100,000 vs female ~0.07/100,000 (males >3× higher, 1999–2010). - Age: highest death rates in adults ≥65 years (males 0.42, females 0.18 per 100,000). - Seasonality: strong winter predominance (heating season, power outages). - Global: CO poisoning is a leading cause of poisoning death worldwide; incidence and trends analyzed via GBD 1990–2021 (joinpoint/ARIMA; PMC12373207). Rates are higher where unvented biomass/coal heating and gas water heaters are common.
Prevalence framing for the KB (PrevalenceMeasureEnum): best modeled as ANNUAL_INCIDENCE (ED visits ~30/100,000/year in the US; deaths ~0.1–0.4/100,000/year), not a chronic point prevalence. prevalence_class qualitatively COMMON among acute poisonings.
Population demographics. Higher burden in lower-income households (older/unmaintained appliances), disaster-affected populations (generators), and in regions with indoor combustion heating/cooking. Intentional CO poisoning (suicide) skews male and adult.
Sources: CDC QuickStats 1999–2010; CDC NVSS 2010–2015; USAFacts 2022; GBD 1990–2021 PMC12373207.
Core principle: diagnosis requires clinical suspicion (nonspecific symptoms + compatible exposure history, often multiple household members or a pet affected) plus direct COHb measurement. Standard pulse oximetry is falsely reassuring.
Laboratory / functional tests. - Carboxyhemoglobin (COHb) by CO-oximetry on arterial or venous blood (venous adequate for the level) — the confirmatory test. LOINC 20563-3. Interpret against baseline: nonsmoker <3%; smoker up to ~10–15%. Elevation confirms exposure; magnitude does not reliably grade severity. - Non-invasive pulse CO-oximetry (multi-wavelength, e.g., SpCO) — screening/triage; correlates imperfectly with blood COHb (PMC10890311). - ABG/VBG with lactate: metabolic acidosis, elevated lactate = severity markers. Measured (not calculated) SaO₂ needed. - Cardiac troponin, ECG — screen all moderate–severe poisonings for myocardial injury/ischemia (prognostic). - CK, renal function, urinalysis — rhabdomyolysis/AKI. - Pregnancy test in women of childbearing age (alters HBO threshold).
Imaging. - CT/MRI brain: bilateral symmetric globus-pallidus lesions; DWI restricted diffusion acutely; diffuse white-matter demyelination subacutely — supports diagnosis and prognosticates DNS risk. Advanced MRI (DTI, MRS, CEST-glutamate) is research-grade.
Biomarkers (investigational for DNS prediction). S100B, neuron-specific enolase (NSE), GFAP, and myelin-related autoantibodies have been studied as predictors of delayed encephalopathy but are not standard of care.
Genetic/omics testing: Not Applicable for diagnosis.
Clinical criteria / differential diagnosis. No formal DSM/ICD diagnostic criteria set beyond exposure + elevated COHb + compatible illness. Differential: viral illness/influenza, gastroenteritis/food poisoning, migraine, acute coronary syndrome, stroke, other toxic gas/cyanide exposure (concurrent in fires — consider cyanide co-toxicity), and psychiatric/functional disorders. Clues favoring CO: multiple people/pets ill in the same environment, symptoms improving away from home, winter/heating context.
Screening. Not a population lab-screening target; home CO alarms are the practical "screening" tool for asymptomatic detection of dangerous ambient levels.
Sources: StatPearls NBK557888; The Diagnosis and Treatment of CO Poisoning PMC6381775; CO-oximetry correlation PMC10890311.
Sources: Weaver NEJM 2002 PMID 12362006; Predictors of delayed encephalopathy PMC11979149.
Immediate / supportive (MAXO: supportive care MAXO:0000950).
- Remove from exposure; secure airway, breathing, circulation; treat seizures, hypotension, arrhythmia; cardiac monitoring; correct acidosis by restoring oxygenation/perfusion.
Normobaric oxygen — first-line (MAXO: oxygen therapy MAXO:0035013; therapeutic agent dioxygen CHEBI:15379).
- High-flow 100% O₂ via non-rebreather mask (or ETT) for all suspected/confirmed cases. Rationale: accelerates COHb elimination. CO half-life ~300 min (4–5 h) on room air → ~60–90 min on 100% normobaric O₂ → ~20–30 min on hyperbaric O₂. Continue until asymptomatic and COHb near-normal (typically <3–5%).
Hyperbaric oxygen (HBO) therapy (MAXO: hyperbaric oxygen therapy MAXO:0000257).
- Mechanism/rationale: 100% O₂ at 2.5–3.0 ATA dramatically shortens COHb half-life, rapidly dissociates CO from cytochrome c oxidase and myoglobin, and is proposed to reduce lipid peroxidation, leukocyte–endothelial adhesion, and the immune-mediated demyelination cascade — potentially preventing delayed neurological sequelae, not just clearing COHb.
- Indications (UHMS 2020 / clinical consensus): consider HBO — ideally within 6 h, no later than ~24 h — for patients with loss of consciousness (any duration), neurologic deficits/abnormal cognition, cardiac ischemia/arrhythmia, severe metabolic acidosis, COHb >25% (adults), and pregnancy (lower threshold, generally symptomatic exposure or COHb >15–20%, because fetal COHb is higher and clears slowly). Prolonged HBO/oxygen may be warranted after methylene-chloride exposure (ongoing endogenous CO production).
- Evidence base (conflicting):
- Thom et al., 1995 — prospective RCT: HBO reduced incidence of DNS in mild–moderate CO poisoning presenting within 6 h (PMID 7710151).
- Weaver et al., NEJM 2002 — quadruple-blinded RCT: three HBO sessions within 24 h reduced cognitive sequelae at 6 weeks (25% vs 46%) and at 12 months (PMID 12362006).
- Scheinkestel et al., MJA 1999 — RCT found no benefit (methodological differences; delayed/varied protocols) (PMID 10092916).
- Cochrane review (Buckley et al., 2011, CD002041) concluded evidence is insufficient/conflicting to define which patients benefit — HBO remains standard practice for severe poisoning at many centers despite equipoise.
Pharmacogenomics / targeted / gene / cell / RNA therapies: Not Applicable (no molecular-target drug therapy). Experimental adjuncts studied mainly in models: erythropoietin (neuroprotection; rat serum-biomarker study PMC3586885), N-acetylcysteine, hypothermia, and — as an experimental antidote concept — engineered high-affinity CO-scavenger molecules (e.g., recombinant neuroglobin/"CO-scavenger" therapeutics in preclinical development to accelerate CO removal). None are approved.
Treatment strategy summary. All symptomatic patients → immediate high-flow 100% O₂ + supportive care; risk-stratify (LOC, neuro deficit, cardiac ischemia, acidosis, COHb, pregnancy) → refer for HBO if indicated and available within the therapeutic window. Arrange neuropsychological follow-up to detect DNS.
Adverse events. HBO risks: barotrauma (middle ear/sinus, rare pulmonary), oxygen toxicity seizures, confinement anxiety, transient myopia. Normobaric high-FiO₂ is generally safe over the short treatment course.
Sources: UHMS HBO indications 2020; Weaver NEJM 2002; Thom 1995 PMID 7710151; Scheinkestel 1999 PMID 10092916; Cochrane CD002041.
Primary prevention (the highest-yield domain). - CO alarms/detectors in homes near sleeping areas and on every level (MAXO/behavioral: environmental intervention). Legislative mandates for residential CO alarms reduce fatalities; battery replacement and testing emphasized. - Appliance safety: annual professional inspection/maintenance of furnaces, water heaters, and vents; never use ovens/ranges for heating. - Generator safety: operate portable generators outdoors, ≥20 ft from windows/doors/vents, never indoors/garages (key message during storms/outages). - Vehicle/engine safety: never run engines in attached/closed garages; check exhaust systems. - No indoor charcoal grills / camp stoves. - Public health education, especially before winter and after disasters; CDC/EPA campaigns.
Secondary prevention (early detection). - CO alarms detecting dangerous ambient levels before symptoms; prompt evaluation of clustered household symptoms; consider CO in nonspecific winter illness ("influenza-like" clusters).
Tertiary prevention (limiting sequelae in the poisoned). - Prompt high-flow/hyperbaric oxygen within the therapeutic window; neuropsychological follow-up to identify and rehabilitate DNS; removal/remediation of the CO source before discharge to prevent re-exposure.
Prophylaxis / immunization / genetic screening / counseling: vaccination and genetic counseling are Not Applicable. "Prophylaxis" = engineering/behavioral source control + alarms.
Sources: CDC clinical/disaster guidance; Yoon 1998 PMID 9496987.
NCBITaxon:9615) and cat (Felis catus, NCBITaxon:9685) — pets are a classic "sentinel" for household CO exposure. Also documented in birds (historically the "canary in the coal mine," Serinus canaria), which are especially sensitive due to high metabolic/respiratory rates.Sources: Thom PNAS 2004 (rat); veterinary toxicology consensus (background).
NCBITaxon:10116) — the dominant model. Standard induced-exposure protocols (e.g., 1,000 ppm 40 min then 3,000 ppm 20 min) reproduce: transient hippocampal MBP degradation (Hara et al., PMID 20633582), immune-mediated delayed neuropathology and learning deficits (Thom et al., PMID 15342916), decreased hippocampal neural precursor cells in DEACMP models (Nat Sci Rep, s41598-021-85860-9), altered nicotinic cholinergic signaling (PMID 24704181), and neuroprotection studies (erythropoietin, PMC3586885). Model type: induced (inhalational exposure), not genetic.NCBITaxon:10090) — used for oxidative-stress/ROS-source dissection (mitochondria/xanthine oxidase/NADPH oxidase) and inflammatory-pathway studies; transgenic/knockout mice (e.g., NOS, NADPH oxidase subunits) dissect specific mechanistic arms.Phenotype recapitulation. Rodent models reproduce the biphasic course (acute exposure → delayed neuropathology), the globus-pallidus/hippocampal vulnerability, demyelination, and the autoimmune anti-MBP mechanism — strong construct/face validity, including the pivotal MBP-tolerance experiment establishing causation.
Limitations. Species differences in CO tolerance and COHb kinetics; some protocols produce MBP degradation without measurable cognitive deficit (dose-dependence), highlighting a human–model translational caveat (HUMAN_MODEL_MISMATCH): the immune-mediated DNS mechanism is best characterized in rodents, and its quantitative fidelity to human DNS remains an open translational question.
Resources: MGI/RGD for mouse/rat strains; primary literature via PubMed. No dedicated CO-poisoning model repository (it is an induced-exposure paradigm, not a genetic line).
Sources: Thom PNAS 2004 PMID 15342916; MBP degradation PMID 20633582; Neural precursor cells Sci Rep; Nicotinic cholinergic PMID 24704181.
| Domain | Term | ID |
|---|---|---|
| Disease | carbon monoxide poisoning | MONDO:0021113 (verify) |
| Chemical (toxicant) | carbon monoxide | CHEBI:17245 |
| Chemical (therapy) | dioxygen | CHEBI:15379 |
| Chemical (source) | dichloromethane | CHEBI:15767 |
| Phenotype | Headache | HP:0002315 |
| Phenotype | Syncope | HP:0001279 |
| Phenotype | Seizure | HP:0001250 |
| Phenotype | Confusion | HP:0001289 |
| Phenotype | Parkinsonism | HP:0001300 |
| Phenotype | Memory impairment | HP:0002354 |
| Phenotype | Myocardial infarction | HP:0001658 |
| Phenotype | Nausea and vomiting | HP:0002017 |
| Phenotype | Dyspnea | HP:0002094 |
| Process | oxidative phosphorylation | GO:0006119 |
| Process | mito. electron transport, cyt c → O₂ | GO:0006123 |
| Process | response to oxidative stress | GO:0006979 |
| Process | ROS metabolic process | GO:0072593 |
| Process | cellular response to hypoxia | GO:0071456 |
| Process | inflammatory response | GO:0006954 |
| Process | adaptive immune response | GO:0002250 |
| Cell | neuron | CL:0000540 |
| Cell | oligodendrocyte | CL:0000128 |
| Cell | microglial cell | CL:0000129 |
| Cell | CD4+ T cell | CL:0000624 |
| Cell | erythrocyte | CL:0000232 |
| Cell | cardiac myocyte | CL:0000746 |
| Anatomy | brain | UBERON:0000955 |
| Anatomy | globus pallidus | UBERON:0001875 |
| Anatomy | cerebral white matter | UBERON:0002316 |
| Anatomy | hippocampus | UBERON:0002421 |
| Anatomy | heart | UBERON:0000948 |
| Subcellular | mitochondrion | GO:0005739 |
| Subcellular | respiratory chain complex IV | GO:0005751 |
| Subcellular | myelin sheath | GO:0043209 |
| Treatment | oxygen therapy | MAXO:0035013 (verify) |
| Treatment | hyperbaric oxygen therapy | MAXO:0000257 (verify) |
| Treatment | supportive care | MAXO:0000950 |
| Lab | Carboxyhemoglobin/Hb.total | LOINC 20563-3 |
just validate-terms-file and runoak … info per the anti-hallucination SOP.evidence: snippet, run just fetch-reference PMID:XXXX and confirm the exact substring (e.g., PMIDs 12362006, 7710151, 15342916, 24773392, 20633582, 32594050, 24704181, 10092916, 9496987).evidence_source tagging: Weaver/Thom-1995/Scheinkestel = HUMAN_CLINICAL; Thom PNAS 2004, MBP-degradation, EPO, nicotinic-cholinergic studies = MODEL_ORGANISM; ROS-source dissection = mix of IN_VITRO/MODEL_ORGANISM (split items accordingly).KNOWLEDGE_GAP / HUMAN_MODEL_MISMATCH candidates: (a) whether the rodent anti-MBP autoimmune DNS mechanism quantitatively explains human delayed encephalopathy; (b) which patients benefit from HBO (unresolved per Cochrane); (c) validity of serum biomarkers (S100B/NSE/GFAP) for DNS prediction.Bottom line: Carbon monoxide poisoning is an acute environmental toxic-inhalation syndrome (MONDO:0021113, ICD-10 T58, MeSH D002249) with no genetic etiology. Its pathophysiology is a dual insult — carboxyhemoglobin-mediated hypoxia plus direct mitochondrial/heme-protein toxicity, oxidative/ischemia-reperfusion injury, and a distinctive immune-mediated (anti-MBP) delayed demyelinating cascade that produces delayed neuropsychiatric sequelae. The brain (globus pallidus, white matter, hippocampus) and heart bear the injury. Management is 100% oxygen ± hyperbaric oxygen (benefit best-supported by Weaver 2002 but contested by Scheinkestel/Cochrane), and the disease is highly preventable through CO alarms and combustion-source safety. Curate the genetic/inheritance sections as Not Applicable, verify all ontology IDs and PMID snippets against the dismech validation stack before committing, and flag the HBO-benefit question and rodent-DNS translational fidelity as knowledge gaps.